Prostate cancer relapse treatment could be cut from 35 visits to just five. See how new radiation technology may change your ...

Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...

Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...

Prostate cancer is Australia's most commonly diagnosed cancer. One in six men will be diagnosed by the time they turn 85. Cancers are abnormal groups of cells that grow uncontrollably and start ...

Brachytherapy and proton therapy are radiation therapies, while HIFU and TULSA are focal therapies with distinct mechanisms. Medicare typically covers HIFU but not TULSA, with potential future ...

Recent advances in prostate cancer radiotherapy have prioritized techniques that minimize treatment-related toxicity and ...

For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...

Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...

From radiopharmaceuticals to hypofractionated radiation therapy, one expert explained the current landscape of radiation treatments for prostate cancer. Radiopharmaceuticals, defined by the National ...

For many men with prostate cancer, the word “radiotherapy” still conjures up weeks of daily hospital trips: 20 or more sessions, Monday to Friday, for a month or longer. A new NHS England programme ...